Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Procyon Corp. (OTC: PCYN).

Full DD Report for PCYN

You must become a subscriber to view this report.


Recent News from (OTC: PCYN)

Biotech Weekly: Reviewing The
Welcome to this week's edition of Biotech Weekly! While biotech has had a very tumultuous last few weeks, the indexes had a good week with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) rising 4.0% and the S&P Biotech ETF (NYSEARCA: XBI ) gaining 5.4% bringing the IBB to a 16.3% YTD...
Source: SeekingAlpha
Date: September, 01 2015 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-150.140.140.140.141,000
2018-08-140.140.140.140.141,000
2018-08-130.140.140.140.1416,692
2018-08-10N/A0.14N/AN/A0
2018-08-09N/A0.14N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1315,52416,69293.0026Short
2018-07-311,0001,000100.0000Short
2018-07-305,00010,00050.0000Short
2018-06-2610,00013,63973.3192Short
2018-04-1750,00058,30085.7633Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PCYN.


About Procyon Corp. (OTC: PCYN)

Logo for Procyon Corp. (OTC: PCYN)

Procyon Corporation is a holding company for its subsidiary Amerx HealthCare Corporation which was acquired in . Amerx develops and markets advanced proprietary skin and wound care products used in the treatment of wounds, ulcers, burns, surgical incisions, cuts, scrapes, abrasions, dermatitis, inflammation and other skin problems. Amerx provides skin and wound care products through its proprietary brand, Amerigel. Amerigel contains the proprietary antimicrobial agent, Oakin, proven effective against bacteria commonly found in wounds including MRSA. Manufacturing and packaging activities are performed pursuant to current good manufacturing practices CGMP as defined under the United States Federal Food, Drug and Cosmetic Act FFDC Act

 

Contact Information

 

 

Current Management

  • Regina W. Anderson / CEO
  • John C. Anderson / President, CFO
    • Over years experience in capital markets on national and international exchanges including TSX , NYSE, NASDAQ, London AIM and Swiss Stock Exchange, Currently CEO of Triumph Gold where he has raised over million.

Current Share Structure

  • Market Cap: $1,292,382 - 03/09/2018
  • Issue and Outstanding: 8,077,388 - 10/04/2017

 


Recent Filings from (OTC: PCYN)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 14 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 16 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: October, 12 2017
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: October, 11 2017
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: October, 11 2017
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: September, 28 2017

 

 


Daily Technical Chart for (OTC: PCYN)

Daily Technical Chart for (OTC: PCYN)


Stay tuned for daily updates and more on (OTC: PCYN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: PCYN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PCYN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of PCYN and does not buy, sell, or trade any shares of PCYN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/